knowledge -WSS

knowledge

author：focus 2025-09-03 11:57:40 - browse：78614

Scientist Nour Tabidi prepares a DNA sample in a lab. -- health coverage from STAT — Scientist Nour Tabidi prepares a DNA sample in a lab at Thermo Fisher's recently opened manufacturing plant in Plainville. John Tlumacki/Globe Staff

Thermo Fisher Scientific’s giant plant to manufacture gene therapies for drug companies is barely a year old, but executives at the maker of scientific tools are already talking about expanding.

Standing inside a cavernous unfinished section of the plant, Paul Fitzgerald, vice president and general manager of the site, told a group of biotech executives, journalists, and other visitors that he’s eager to transform it into laboratories. So far, the company is only using about 290,000 of the plant’s more than 400,000 square feet.

“I look forward to you guys giving us a reason to fill up this space,” Fitzgerald quipped during a tour Tuesday of the plant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： FDA clears AI tool for detecting skin cancer

explore

WSS

Research misconduct: Proposed new rules face resistance

Why the world’s most expensive drug might be worth the price

Steward Health Care has deal to sell doctor network to UnitedHealth

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

FDA clears AI tool for detecting skin cancer

EU regulator recommends expanding Mounjaro approval to obesity

hotspot

knowledge

Wikipedia

Medicare details structure of new drug price negotiation program

Why doctors need education on FDA device approval process

Guidelines to prevent youth baseball injuries need more muscle

Readout Newsletter: Merck, J&J, and long Covid

Dobbs anniversary: the lost opportunity of abortion as health care

Abortion pill Supreme Court ruling could impact entire drug industry

The high cost of giving birth even with insurance

Patient advocates debate FDA's accelerated approval process

ChatGPT in medicine: STAT answers readers' burning questions

Test for long Covid? Researchers find new clue in blood samples

focus

Decaf coffee targeted by food safety group under obscure FDA rule

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Washington mulls new rules to avert another Change Healthcare

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

NIH director takes cautious approach to Biden drug pricing priority

Elizabeth Holmes banned from government health programs

focus

hotspot

explore

focus